Guard Therapeutics International AB Stock
Equities
GUARD
SE0021181559
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.8 SEK | -3.36% | 0.00% | -19.55% |
Sales 2023 | - | Sales 2024 * | - | Capitalization | 300M 3.28B 410M |
---|---|---|---|---|---|
Net income 2023 | -113M -1.23B -154M | Net income 2024 * | -99M -1.08B -135M | EV / Sales 2023 | - |
Net cash position 2023 * | 67M 732M 91.58M | Net cash position 2024 * | 70M 765M 95.68M | EV / Sales 2024 * | - |
P/E ratio 2023 |
-3.18
x | P/E ratio 2024 * |
-3.03
x | Employees | 12 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 60.37% |
1 day | -3.36% | ||
Current month | +55.68% | ||
1 month | +64.57% | ||
3 months | +17.07% | ||
6 months | -10.84% | ||
Current year | -19.55% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 18-11-30 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 20-09-13 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 21-04-30 |
Göran Forsberg
BRD | Director/Board Member | 61 | 19-05-28 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 22-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 28.8 | -3.36% | 1 738 |
24-04-26 | 29.8 | 0.00% | 9,584 |
24-04-25 | 29.8 | -2.61% | 7,991 |
24-04-24 | 30.6 | +3.38% | 3,887 |
24-04-23 | 29.6 | +2.78% | 9,270 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 09:12 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.55% | 27.35M | |
+2.21% | 42.75B | |
+47.75% | 41.61B | |
+11.30% | 41.34B | |
-12.36% | 26.59B | |
+7.89% | 25.49B | |
-23.73% | 18.12B | |
+29.79% | 12.24B | |
-1.99% | 11.76B | |
+8.07% | 11B |
- Stock Market
- Equities
- GUARD Stock